Partner Hospitals

Founded in 1892, it has reached leading domestic and international standards in many fields, such as adult living donor liver transplantation, early diagnosis and treatment of lung cancer, cardiac interventional therapy, neurosurgery and functional neurosurgery, integrated traditional Chinese and Western medicine for severe pancreatitis, and allogeneic combined larynx-trachea-thyroid transplantation.

Founded in 1920. It is the supporting institution for the National Center for Stomatology and the National Clinical Research Center for Oral Diseases. Its Department of Plastic and Reconstructive Surgery remains the world’s largest plastic surgery medical center and China’s leading center for plastic surgery in medical treatment, teaching and research. Annual outpatient and emergency visits exceed 4.8 million, inpatient admissions over 150,000, inpatient surgeries more than 90,000, and outpatient surgical procedures over 170,000.

Founded in 1957, it is China’s first Grade A tertiary specialized hospital focusing on the diagnosis and treatment of cardiothoracic diseases after the founding of the People’s Republic of China. Centered on two major discipline clusters: thoracic tumors and cardiovascular diseases, it masters the most extensive spectrum and full range of diagnostic and therapeutic technologies for cardiothoracic diseases in China. Annual outpatient and emergency visits exceed 860,000, with more than 28,000 surgeries performed each year. The proportion of Grade-III and Grade-IV surgeries is over 90%. Its surgical volume for tracheal and mediastinal tumors ranks No.1 nationwide, lung tumor surgery volume ranks No.2 nationwide, and esophageal surgery volume is among the top in China and ranks No.1 in the city.

Founded in 1904. The hospital registers more than 5.3 million annual outpatient and emergency visits, over 180,000 annual inpatient admissions, and more than 120,000 annual inpatient operations. The leading specialties including Orthopedics and Endocrinology and Metabolism enjoy nationally top-tier medical capabilities. The cure rates for complex trauma, hand and foot microsurgery, and refractory endocrine diseases rank among the highest in China.

Founded in 1931. It is equipped with 22 high-end medical devices including Da Vinci surgical robots, MR Linac, TOMO, LA, PET-CT, PET-MR and 5.0T MRI. Annual outpatient visits: 2.5 million; annual inpatient admissions: 170,000; annual surgeries: 80,000; annual radiotherapy sessions: 420,000. The overall 5-year survival rate of patients with malignant tumors reaches 72%.

Founded in 1907, the hospital has an annual total of over 6 million outpatient and emergency visits, nearly 200,000 inpatient admissions and more than 100,000 surgeries. As Shanghai’s first medical institution offering foreign-related medical services, it is a designated medical facility for consulates of 10 countries. It has served more than 600,000 foreign patients from over 100 countries and regions worldwide.

Founded in 1844, it was the first Western medicine hospital after the opening of Shanghai port. It is equipped with advanced medical equipment including dual-source photon-counting CT, PET-CT, PET-MR, Da Vinci surgical robot, X-ray stereotactic radiotherapy system, TomoTherapy system, linear accelerator (LA), 320-row 640-slice ultra-speed spiral CT, hybrid operating room system and telemedicine teaching system. The hospital has 2,750 authorized beds. Annual outpatient and emergency visits reach 7.4584 million, inpatient admissions 268,200, and inpatient surgeries 134,000.